Oak Ridge National Laboratory has released the federal government’s new 2022 Fuel Economy Guide. The report provides the latest fuel efficiency stats and money-saving tips for new and used vehicles.
A team including researchers from the Department of Energy’s Oak Ridge National Laboratory has developed a digital tool to better monitor a condition known as Barrett’s esophagus, which affects more than 3 million people in the United States.
Research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2021 R&D 100 Awards, plus special recognition for a COVID-19-related project.
Nearly a billion acres of land in the United States is dedicated to agriculture, producing more than a trillion dollars of food products to feed the country and the world. Those same agricultural processes, however, also produced an estimated 700 million metric tons of carbon dioxide equivalent in 2018, according to the U.S. Department of Agriculture.
ORNL has licensed its wireless charging technology for electric vehicles to Brooklyn-based HEVO. The system provides the world’s highest power levels in the smallest package and could one day enable electric vehicles to be charged as they are driven at highway speeds.
A new tool that simulates the energy profile of every building in America will give homeowners, utilities and companies a quick way to determine energy use and cost-effective retrofits that can reduce energy and carbon emissions.
Kathy McCarthy, associate laboratory director for Fusion and Fission Energy and Science at the Department of Energy’s Oak Ridge National Laboratory, has been elected fellow of the American Nuclear Society for her nationally and internationally recognized leadership in nuclear energy and fusion.
An analysis published in the Proceedings of the National Academy of Sciences and led by researchers from the U.S. Department of Energy’s Oak Ridge National Laboratory has received the 2021 Sustainability Science Award from the Ecological Society of America.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.